Search results
FDA expands approval of first gene therapy for rare form of muscular dystrophy
WPTZ Burlington· 4 days agoLast year, the drug — Elevidys, from the biotech company Sarepta Therapeutics — was approved to...
Global Nonprofit CureDuchenne to Host Informational Webinars Following FDA Label Expansion of...
KNDO - KNDU Tri-Cities· 6 days agoCureDuchenne, a global nonprofit committed to finding and funding a cure for Duchenne muscular dystrophy, will host webinars in English ...
Gene Therapy for Duchenne Muscular Dystrophy Gets Expanded Approval
MedPage Today· 6 days agoThe FDA expanded the approval of delandistrogene moxeparvovec-rokl (Elevidys) gene therapy for ...
FDA Expands Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy
The Woonsocket Call· 6 days agoToday, the U.S. Food and Drug Administration expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene therapy for the treatment of Duchenne muscular ...
Sarepta Therapeutics, Ryan Specialty rise; Autodesk, Trump Media fall, Friday, 6/21/2024
Associated Press via Yahoo Finance· 5 days agoU.S. regulators approved the company's treatment for children with Duchenne muscular dystrophy. Trump Media & Technology Group Corp., ...
Is Pfizer's Pain Sarepta Therapeutics' Gain? Don't Bet on It.
Motley Fool via Yahoo Finance· 8 hours agoWhen one player stumbles in a high-stakes competition, it's often to the glee of the other...
Sarepta surges as investors cheer expanded use of gene therapy
Reuters via Yahoo News· 5 days ago(Reuters) -Sarepta Therapeutics shares surged as much as 40% to a more than three-year high on Friday as an expanded use approval cemented its dominant position in the gene therapy market for ...
Sarepta Therapeutics receives expanded approval for Elevidys | Invezz
Invezz· 6 days agoFood and Drug Administration regarding Elevidys. Elevidys is the company’s treatment for Duchenne muscular dystrophy. The FDA granted ...
Duchenne approval exposes FDA rift over Sarepta gene therapy
BioPharma Dive via Yahoo Finance· 5 days agoPeter Marks’ decision to override the objections of agency staff and broaden use of Elevidys could...
Insider Sale: EVP, General Counsel Ryan Brown Sells 38,957 Shares of Sarepta Therapeutics Inc (SRPT)
GuruFocus.com via Yahoo Finance· 14 hours agoInc (NASDAQ:SRPT) is a biotechnology company focused on the discovery and development of...